US FDA approves Vanda's psychiatric drug - TradingView

Reuters | Feb. 20, 2026, 6 p.m. | Original
US FDA approves Vanda's psychiatric drug TradingView
Trump tariff reversal could cut costs for US energy firms but will likely leave broader flows unchanged - Reuters US FDA approves Vanda's antipsychotic pill, shares climb - Reuters